Safe working practices: RIVM creates a list of 1,400 substances without a European occupational exposure limit for health purposes Employees sometimes come into contact with hazardous substances at work. RIVM has compiled a list of 1,400 hazardous substances for which the European Commission has not yet set an occupational exposure limit.
NS did not adequately protect employees from exposure to chromium (VI) Employees of Dutch Railways (NS) may have been exposed to chromium (VI) between 1970 and 2020. Although it is not known exactly how often or how much this occurred, it is reasonable to assume that NS employees who were exposed to chromium (VI) may develop certain medical conditions.
COVID-19 vaccination estimated to have prevented about 88 thousand hospital admissions in just over one year The COVID-19 vaccinations prevented many hospital admissions in the Netherlands.
Repeat vaccination against COVID-19 now also available for over-60s People aged 60 to 69 years (and people who turn 60 this year) will also have the opportunity to make an appointment for an extra COVID-19 vaccination. Minister Kuipers decided this based on advice from the Health Council of the Netherlands.
Number of tuberculosis patients in the Netherlands increased slightly in 2021 compared to 2020 The number of people with tuberculosis (TB) in the Netherlands increased slightly in 2021, reaching 680. This figure is 9% higher than it was in 2020 (622 patients).
Janssen booster possible as of 25 March People in the Netherlands who cannot get a booster with an mRNA vaccine for medical reasons, or do not want an mRNA vaccine as a booster, can make an appointment for a booster vaccination with Janssen from Wednesday 23 March on.
Protection from COVID-19 booster wanes slightly after 3 months among over-70s In the period from 1 February to 8 March 2022, the first indications were observed that protection against hospital admission after COVID-19 booster vaccination decreases over time in people over 7
Novavax vaccine available The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.
First COVID-19 vaccination in the Netherlands on 8 January 2021 If the European Medicines Agency (EMA) approves BioNTech/Pfizer’s COVID-19 vaccine next week, the first people in the Netherlands will receive the COVID-19 vaccine on Friday 8 January 2021.
Possible start of COVID-19 vaccination in early January If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.